Steven L. Tuch - 12 Dec 2022 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Chief Financial Officer
Signature
/s/ Paul J. Sekhri as Attorney-in-Fact
Issuer symbol
VTVT
Transactions as of
12 Dec 2022
Net transactions value
$0
Form type
4
Filing time
13 Dec 2022, 16:02:20 UTC
Previous filing
13 Dec 2022
Next filing
13 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Director stock option (right to buy) Award $0 +500,000 $0.000000 500,000 12 Dec 2022 Class A Common Stock 500,000 $0.8000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 An option to purchase 166,666 shares vests on December 12, 2023, and the remaining option to purchase 333,334 shares vests in equal quarterly installments over the two-year period beginning on December 12, 2023, subject to continued employment.